The Diatrizoate Meglumine Injection, cataloged under National Stock Number 6505-01-333-6656, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-333-6656 |
| Primary Part Number | NDC50419-0192-85 |
| Item Name | Diatrizoate Meglumine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 150.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 60.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 1 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC50419-0192-85 PRIMARY | Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc (USA) |
NSN 6505-01-333-6656 is a Diatrizoate Meglumine Injection, manufactured by Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-333-6656 has 1 manufacturer part number on file: NDC50419-0192-85 (Bayer Healthcare Pharmaceuticals Inc Dba Bayer Healthcare Pharmaceuticals Inc).
Key specifications for NDC50419-0192-85: Administration: INTRAVENOUS; Primary Container Content Quantity: 150.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.